TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of T cell receptor-engineered T cell therapies for the treatment of cancer, appointed Justin McCue, chief technology officer. McCue joins TScan with over 20 years of experience in biologics and cell therapy manufacturing, including process/analytical development, technical operations, clinical development, and commercialization of T cell therapy products. McCue joins TScan from Avectas, where he...